Actively Recruiting
Rehabilitation Intervention for COPD Combined With Cardiovascular and Cerebrovascular Diseases
Led by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Updated on 2025-07-29
50000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to identify and diagnose people with chronic obstructive pulmonary disease (COPD) who also have cardiovascular and cerebrovascular diseases. It evaluates the effects of pulmonary rehabilitation exercise combined with usual care compared to routine care alone. The study also seeks to develop a comprehensive rehabilitation management model for COPD patients to improve diagnosis and treatment standards. Participants are randomly assigned to one of two groups. One group receives pulmonary rehabilitation exercises plus usual care for three months, while the other group follows routine care based on the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2025 guidelines. After the three-month treatment period, changes in acute exacerbation frequency, COPD Assessment Test (CAT) scores, St. George’s Respiratory Questionnaire (SGRQ) results, lung ventilation, and diffusion function are observed for one year. During the study, participants undergo assessments including lung function tests and questionnaires measuring respiratory health and quality of life. Researchers track acute exacerbation frequency over time and monitor blood pressure, blood lipids, and fasting blood glucose levels. The study lasts approximately four years, covering treatment, follow-up, and long-term observation to evaluate the impact of rehabilitation interventions on COPD combined with cardiovascular and cerebrovascular diseases.
CONDITIONS
Brief Title
Rehabilitation Intervention for COPD Combined With Cardiovascular and Cerebrovascular Diseases
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Committed to following the study protocol and completing the research process
- Aged 18 years or older, any gender
- Signed informed consent form
You will not qualify if you...
- Severe mental illness
- Condition requiring immediate hospitalization or severe, life-threatening illness
- Pregnant, breastfeeding, or using inappropriate contraception
- Refusal to cooperate with follow-up questionnaires or specimen collection
- Currently participating in other interventional clinical drug trials
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 3 months
Participants receive either pulmonary rehabilitation exercise and usual care or routine care treatments for COPD combined with cardiovascular and cerebrovascular diseases.
Visits as per treatment schedule over 3 months
Duration - 1 year
Participants are observed for changes in acute exacerbation frequency, respiratory function, and quality of life assessments for one year after treatment.
Periodic visits for assessment during follow-up
Trial Site Locations
Total: 1 location
1
Union hospital, Tongji Medical college, Huazhong University of Science and Technology
Wuhan, Hubei, China, 430022
Actively Recruiting
Research Team
G
Guanzhou Ma
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here